A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- BioMarin Pharmaceutical
- Study ID
- NCT07126262
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Hypochondroplasia
Eligibility Criteria
- Sex
- ALL
- Age
- 0 Months - 36 Months
- Healthy Volunteers
- Not accepted
Interventions
- Vosoritide — DRUGThe vosoritide dose administered will be based on the participant's weight and will follow the weight-band dosing regimen approved for ACH
- Placebo — DRUGSubcutaneous injection of recommended dose of placebo
Study Details
The purpose of this study is to evaluate the safety and efficacy of daily administration of vosoritide in participants with HCH aged 0 to \< 36 months over a 52-week period.
Key Dates
- Start date
- Jul 30, 2025
- Status verified
- Mar 2026
- Primary completion
- Jun 30, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Vosoritide injection with vial and syringeSubcutaneous injection of recommended dose of vosoritide based on weight-band dosing once daily.
- Placebo Comparator: Placebo injection with vial and syringeSubcutaneous injection of recommended dose of placebo
Primary Outcome Measure
Incidence of treatment-emergent adverse events [ Time Frame: From baseline to end of treatment at 52 weeks ]
Central Contacts
- Trial Specialist1-800-983-4587
Locations (10)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Phoenix Children's Hospital - Thomas Campus (Main) | Phoenix | Arizona | 85016 | - |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | - |
| Benioff Children's Hospital - Oakland | Oakland | California | 94609 | - |
| Children's National Medical Center | Washington D.C. | District of Columbia | 20010 | - |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | - |
| The Johns Hopkins University School of Medicine | Baltimore | Maryland | 21205 | - |
| University of Minneasota Masonic Children's Hospital | Minneapolis | Minnesota | 55454 | - |
| University of Missouri | Columbia | Missouri | 65211 | - |
| Cook Children's Endocrinology | Fort Worth | Texas | 76104 | - |
| Children's Wisconsin - Fox Valley Hospital | Neenah | Wisconsin | 54956 | - |
Find similar trials in Phoenix, AZ
By research site
Phoenix Children's Hospital - Thomas Campus (Main)· Phoenix, AZCedars-Sinai Medical Center· Los Angeles, CABenioff Children's Hospital - Oakland· Oakland, CAChildren's National Medical Center· Washington D.C., DCAnn & Robert H. Lurie Children's Hospital of Chicago· Chicago, ILThe Johns Hopkins University School of Medicine· Baltimore, MD
Related Studies
- A Multicenter Multinational Observational Study of Children With HypochondroplasiaRecruiting · BioMarin Pharmaceutical · Phoenix, Arizona
- Prospective Clinical Assessment Study in Children With HypochondroplasiaRecruiting · QED Therapeutics, a BridgeBio company · Oakland, California
- An Interventional Study of Infigratinib in Children With HypochondroplasiaPHASE2/PHASE3 · Enrolling By Invitation · QED Therapeutics, a BridgeBio company · Oakland, California
- Long-Term Extension Study of Vosoritide to Treat Children With HypochondroplasiaPHASE3 · Enrolling By Invitation · BioMarin Pharmaceutical · Wilmington, Delaware